跳至主要内容
临床试验/CTRI/2022/09/045386
CTRI/2022/09/045386尚未招募未知

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH ALOPECIA AREATA INVOLVING MORE THAN 50% OF SCALP SURFACE AREA: A DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL.

Department of Dermatology venereology and leprosy Burdwan medical college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Alopecia areata involving more than 50% of scalp surface area.
  • Age- 15-60 years

排除标准

  • Immunosupressed patients like HIV,TB, Hepatitis
  • Patients on chemotherapy.
  • Pregnancy and lactation
  • Patients with psoriasis or seborrhoeic dermatitis.
  • Patients treated with any topical or systemic therapy within 3 month of 1st visit

研究者

发起方
Department of Dermatology venereology and leprosy Burdwan medical college and hospital

相似试验